Literature DB >> 31401147

Epigenetically Upregulated MicroRNA-602 Is Involved in a Negative Feedback Loop with FOXK2 in Esophageal Squamous Cell Carcinoma.

Meiyue Liu1, Jiarui Yu1, Dan Wang1, Yi Niu1, Siyuan Chen1, Peng Gao1, Zhao Yang1, Huan Wang1, Jie Zhang2, Chao Zhang1, Yue Zhao3, Wanning Hu4, Guogui Sun5.   

Abstract

MicroRNA is an endogenous, small RNA controlling multiple target genes and playing roles in various tumorigenesis processes. In this study, our results revealed that miR-602 expression levels in tumor tissues and preoperative serum from esophageal squamous cell carcinoma (ESCC) patients were higher than those in non-tumorous tissues and healthy volunteers. miR-602 overexpression was closely related to lymph node metastasis and TNM stages and correlated short overall, and it acted as an independent prognostic marker of ESCC. The methylation status of the miR-602 gene indicated more frequent hypomethylation of the CpG sites located upstream of the miR-602 gene in the ESCC tissues than in the adjacent normal tissues, and the methylation status of miR-602 correlated inversely with its expression levels. Subsequently, miR-602 overexpression promoted ESCC proliferation and metastasis and regulated cell cycles in vitro and in vivo. Mechanistically, a dual-luciferase experiment validated that Fork head box (FOX)K2 (FOXK2) was a direct target of miR-602. More importantly, systemic delivery of formulated miR-602 antagomir could reduce tumor growth and increased FOXK2 protein expression in nude mice. This work provides novel insight into the molecular pathogenesis of ESCC.
Copyright © 2019 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  biomarker; esophageal squamous cell carcinoma; metastasis; methylation; miRNAs

Mesh:

Substances:

Year:  2019        PMID: 31401147      PMCID: PMC6822237          DOI: 10.1016/j.ymthe.2019.07.006

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  43 in total

1.  Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.

Authors:  Chunni Zhang; Cheng Wang; Xi Chen; Cuihua Yang; Ke Li; Junjun Wang; Juncheng Dai; Zhibin Hu; Xiaojun Zhou; Longbang Chen; Yanni Zhang; Yanfang Li; Hong Qiu; Jicheng Xing; Zhichao Liang; Binhui Ren; Chen Yang; Ke Zen; Chen-Yu Zhang
Journal:  Clin Chem       Date:  2010-10-13       Impact factor: 8.327

2.  Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.

Authors:  Shu Chen; Simin Jiang; Fen Hu; Yongjian Xu; Tao Wang; Qi Mei
Journal:  Oncol Rep       Date:  2017-02-16       Impact factor: 3.906

3.  MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.

Authors:  Hao Li; Zun-Qiang Zhou; Zhang-Ru Yang; Da-Nian Tong; Jiao Guan; Bao-Jie Shi; Jia Nie; Xian-Ting Ding; Bin Li; Guang-Wen Zhou; Zheng-Yun Zhang
Journal:  Hepatology       Date:  2017-05-18       Impact factor: 17.425

4.  FOXKs promote Wnt/β-catenin signaling by translocating DVL into the nucleus.

Authors:  Wenqi Wang; Xu Li; Moonsup Lee; Sohee Jun; Kathryn E Aziz; Lin Feng; My Kim Tran; Nan Li; Pierre D McCrea; Jae-Il Park; Junjie Chen
Journal:  Dev Cell       Date:  2015-03-23       Impact factor: 12.270

5.  Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.

Authors:  Helen M Heneghan; Nicola Miller; Aoife J Lowery; Karl J Sweeney; John Newell; Michael J Kerin
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

6.  MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer.

Authors:  Chunlin Ou; Zhenqiang Sun; Xiayu Li; Xiaoling Li; Weiguo Ren; Zailong Qin; Xuemei Zhang; Weitang Yuan; Jia Wang; Wentao Yu; Shiwen Zhang; Qiu Peng; Qun Yan; Wei Xiong; Guiyuan Li; Jian Ma
Journal:  Cancer Lett       Date:  2017-04-19       Impact factor: 8.679

7.  miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.

Authors:  Nora Bandi; Samuel Zbinden; Mathias Gugger; Marlene Arnold; Verena Kocher; Lara Hasan; Andreas Kappeler; Thomas Brunner; Erik Vassella
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

8.  hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma.

Authors:  Sumadi Lukman Anwar; Till Krech; Britta Hasemeier; Elisa Schipper; Nora Schweitzer; Arndt Vogel; Hans Kreipe; Reena Buurman; Britta Skawran; Ulrich Lehmann
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

9.  microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer.

Authors:  Sinae Kim; Eunji Lee; Jaeyun Jung; Jong Won Lee; Hee Jung Kim; Jisun Kim; Hyun Ju Yoo; Hee Jin Lee; Sun Young Chae; Sang Min Jeon; Byung Ho Son; Gyungyup Gong; Shyam K Sharan; Suhwan Chang
Journal:  Oncogene       Date:  2018-03-12       Impact factor: 9.867

10.  Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.

Authors:  Xi Liu; Xiaodong Wei; Wei Niu; Dong Wang; Bo Wang; Hao Zhuang
Journal:  Mol Med Rep       Date:  2018-09-07       Impact factor: 2.952

View more
  5 in total

Review 1.  MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

2.  Long non-coding RNA tumor protein 53 target gene 1 promotes cervical cancer development via regulating microRNA-33a-5p to target forkhead box K2.

Authors:  Dan Liao; Xiaomei Liu; Xiuying Yuan; Poling Feng; Zhiwei Ouyang; Yanyan Liu; Cuifen Li
Journal:  Cell Cycle       Date:  2022-01-28       Impact factor: 4.534

3.  miR-602 Mediates the RASSF1A/JNK Pathway, Thereby Promoting Postoperative Recurrence in Nude Mice with Liver Cancer.

Authors:  Cheng Zhou; Yajing Huang; Yongxu Chen; Yingjie Xie; Huihong Wen; Wei Tan; Changjun Wang
Journal:  Onco Targets Ther       Date:  2020-07-10       Impact factor: 4.147

4.  miR-602 Activates NRF2 Antioxidant Pathways to Protect HBMECs from OGD/R-Induced Oxidative Stress via Targeting KEAP1 and HRD1.

Authors:  Chunli Ma; Lei Yang; Qiang Gao; Lihua Wang
Journal:  Dis Markers       Date:  2022-09-24       Impact factor: 3.464

Review 5.  Regulation and roles of FOXK2 in cancer.

Authors:  Yuanyuan Kang; Kexin Zhang; Lixue Sun; Ying Zhang
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.